The Kentucky Cabinet for Health and Family Services presented information earlier this month to the legislature’s Interim Joint Committee on Health Services about the impact of the commonwealth’s use of a single PBM since July 1, 2021 and a single Preferred Drug List (PDL) since Jan. 1, 2021. A key finding was how Kentucky would have spent $282.7 million more in its managed Medicaid program if it had not implemented SB 50, the legislation enacting the single PBM and single PDL.
NCPA
